597642-Awarded - Czech Republic – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – LP s obsahem nirsevimabu 2025

World Biggest Tenders Source

This tender with title 597642-Awarded - Czech Republic – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – LP s obsahem nirsevimabu 2025 -- Contract Value: 8 290 425,00 CZK has been published on Bidding Source portal dated 15 Sep 2025 for the country of Czech Republic. It has been categorized on General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 8 290 425,00 CZK

General Information

Czech Republic

Tender Title :

597642-Awarded - Czech Republic – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – LP s obsahem nirsevimabu 2025
Contract Value: 8 290 425,00 CZK

Tender Type :

Contract Award

Reference No. :

597642

Country :

Czech Republic

Publish Date :

15 Sep 2025

Notice Language :

English

Tender Categories (CPVs) :

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Supplies of medicinal products with the active substance PEMBROLIZUMAB 2023 - 79935-2024 Czech Republic General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Supplies of medicinal products with the active substance PALIVIZUMAB 2023 - 80564-2024 Czech Republic Anti-infectives - joint submission Czech Republic Supplies of medicinal products with the active ingredient PALIVIZUMAB 2023 Czech Republic Supplies of medicinal products with the active substance PEMBROLIZUMAB 2023 Czech Republic Delivery of medicinal products with the active ingredient Aflibercept -- <h6>Dodávka léčivých přípravků s účinnou látkou Aflibercept</h6> Czech Republic Delivery of medicinal products with the active ingredient Faricimab and Brolucizumab -- <h6>Dodávka léčivých přípravků s účinnou látkou Faricimab a Brolucizumab</h6> Czech Republic Czech Republic - LP containing tixagevimab and cilgavimab 2023 - pooled purchase Czech Republic Léčivé přípravky s obsahem norepinefrin-tartarátu - sdužený nákup -- <h6>Medicinal preparations containing norepinephrine-tartrate - consolidated purchase</h6> Czech Republic Czech Republic - Medicinal preparations containing goserelin acetate - combined purchase -- <br><b>Léčivé přípravky s obsahem goserelin-acetátu - sdružený nákup</b> Czech Republic

597642-Awarded - Czech Republic – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – LP s obsahem nirsevimabu 2025

Contract Value: 8 290 425,00 CZK

General Information

Czech Republic

Similar Tenders

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Tenders

Czech Republic Tenders

Europe Tenders

Tenders

info@biddingsource.com